TARGET
saveBCMA
Multiple myeloma plasma-cell antigen.
also known as: tnfrsf17, b-cell maturation antigen
drugs
0
catalysts
0
news
14
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Genentech doubles down on ADC-resistant cancers with $1B DualityBio pactfiercebiotech · 8h ago
- Regeneron ends eye disease trial for anti-CD3 antibody following safety reviewfiercebiotech · 10d ago
- After 2 undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted?fiercebiotech · 14d ago
- Boulevard starts up with $65M to pursue targeted autoimmune drugsbiopharma dive · 16d ago
- Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugsfiercebiotech
comments(0)
5-min edit window · permanent after that